BLACR

Bellevue Life Sciences Acquisition Corp. Rights
BLACR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

BLACR was delisted on the 14th of February, 2025.

Back to rankings

24 hedge funds and large institutions have $1.2M invested in Bellevue Life Sciences Acquisition Corp. Rights in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$135K
2
+$43.7K
3
+$23K
4
UBS Group
UBS Group
Switzerland
+$1.17K
5
CS
Clear Street
New York
+$181

Top Sellers

1
-$8.55K
2
-$5.06K
3
-$46
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$209K
2
$206K
3
$82.8K
4
$71.5K
5
$71.5K
6
$58K
7
$57.5K
8
$57.5K
9
$56K
10
$46K
11
$43.7K
12
$42K
13
$34K
14
$28.1K
15
$28K
16
$28K
17
$28K
18
$23K
19
$17K
20
$6.22K
21
$4.97K
22
$4.78K
23
$1.17K
24
$23
25
–